Skip to content

Clinical trials

Neurotoxicity Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Country / region: United States Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20044
20054
20066
20076
20085
20097
20104
20118
20121
20131
20142
20151
20171
20181
20192
20203
20212
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Terminated12
Recruiting5
Active, not recruiting5
Unknown status2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology11
Gynecologic Oncology Group5
National Cancer Institute (NCI)5
M.D. Anderson Cancer Center4
Case Comprehensive Cancer Center3
Children's Oncology Group3
Radiation Therapy Oncology Group3
University of South Florida3
City of Hope Medical Center2
University of California, San Francisco2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes76
Pain10
Peripheral Nervous System Diseases9
Breast Neoplasms8
Ovarian Neoplasms7
Brain Neoplasms6
Lymphoma6
Central Nervous System Neoplasms5
Fatigue5
Leukemia5

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.